News
On Wednesday January 24, 2024, Université Claude Bernard Lyon 1 (UCBL), Hospices Civils de Lyon (HCL) (HCL), the French National Research Agency (ANR) and Sanofi officially launched the the VIRESP industrial chair, a research project focusing on the development of techniques and tools for analyzing the risk of infection and the morbidity rate of diseases in different populations, but also to determine the benefits of vaccination programs.
On March 19, the local finale of Ma Thèse en 180 secondes will take place, with the 12 finalists. Among them, two are doing their PhD at the CIRI: Xanthe Adams-Ward (LegioPath) et Iris Dadole (Persist).
— Grand Amphithéâtre de l'Université de Lyon - 90 rue Pasteur 69007 Lyon - et en direct sur YoutubeFebruary 29, 2024 is Rare Disease Day. This is an opportunity to thank the clinicians and researchers who are advancing research on this subject at CIRI, as well as our patients!
The ARC Foundation brings together 5 leading cancer researchers for a 45-minute program. It will give the floor to experienced researchers and young talents, all ready to take up, together, the challenges of curing more patients.
The VirPath team was awarded two times during the 2023 research and innovation awards ceremony of the Université Claude Bernard Lyon 1. We look back at these awards and on the research program of the International Associate Laboratory RESPIVIR France-Canada.
Meet with Cyrille Mathieu at the Yggdrasil festival, to learn all about viruses!
— Eurexpo LyonDuring the COVID-19 pandemic, multisystemic inflammatory syndrome affected 1,100 children. Since this first description in 2020, CIRI researchers, HCL clinicians and other international collaborators have discovered that this syndrome existed before COVID-19, and that other infectious agents could lead to this severe inflammatory syndrome in children. These findings are published in the New England Journal of Medicine.
Among the 11 laureates of the PEPR MIE 2023 call for projects (ANRS|Emerging Infectious Diseases), 6 projects involve CIRI teams. Their common aim is to better understand, prevent and control the emergence or re-emergence of infectious diseases.
The PHE3ID/CERP research team has been awarded with one of the first Projets d’Amorçage supported by SHAPE-Med@Lyon
On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.
On October 12, 2023, Sidaction donors visited the laboratory of the LP2L team (A. Cimarelli, L. Etienne). Here's a look back at this successful moment of sharing.
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
New publication - VIV Team in Nature communication
Several CIRI teams carried out this work, published in the journal Science Translational Medicine.
The protein that opens doors to the medicine of the future and treatment of COVID-19
Retrouvez son portrait ici
Antibiotic resistance has made certain infections, sometimes common, such as urinary and respiratory infections, impossible to treat, representing a major setback in the medical care of human and animal patients. This resistance has thus become a major health issue, which has led the WHO (World Health Organization) to establish a list of bacteria in which antibiotic resistance is particularly worrying.In a new study published in the journal mBio, we focused on one of these bacteria that are particularly resistant to antibiotics, Acinetobacter baumannii. The latter is responsible for many opportunistic and nosocomial infections. We have determined the mechanisms that allow this bacterium to rapidly acquire resistance genes from neighboring bacteria.
Maladies infectieuses émergentes
The Club Francophone des Cellules Dendritiques (CFCD) is organizing its annual congress in Paris from October 16 to 17, 2021 on “DC-phering mononuclear phagocyte biology in health and disease". Program and information for registration on http://www.cfcd.fr/meeting/registration.php
— Institut Necker Enfants Malades (INEM), ParisModulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein.